BioSyent Inc.

BioSyent Inc.
Stock Exchange Other OTC
EPS
$0.29
Market Cap
$67.79 M
Shares Outstanding
14.52 M
Public Float
-
BioSyent Inc.
Stock Exchange Toronto Ventures Stock Exchange
EPS
CAD0.38
Market Cap
CAD88.82 M
Shares Outstanding
13.84 M
Public Float
11.35 M

Profile

Address
170 Attwell Drive
Toronto Ontario M9W 5Z5
Canada
Employees -
Website http://www.biosyent.com
Updated 07/08/2019
BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System, and Cysview. The company was founded on April 28, 1947 and is headquartered in Ontario, Canada.

Financials

View All

René C. Goehrum
Chairman, President & Chief Executive Officer
Joseph Arcuri
Independent Director